Nebula Capital Management’s Gilead Sciences GILD Stock Holding History

Nebula Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-9,650	Closed	-$805K	–	13
2016 Q2	$805K	Sell	9,650 -49,350	-84%	-$4.38M	6.38%	8
2016 Q1	$5.42M	Hold	59,000	–	–	3.84%	11
2015 Q4	$5.97M	Hold	59,000	–	–	3.79%	11
2015 Q3	$5.79M	Hold	59,000	–	–	3.91%	13
2015 Q2	$6.91M	Hold	59,000	–	–	4.17%	10
2015 Q1	$5.79M	Buy	+59,000	New	+$5.99M	3.75%	12

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nebula Capital Management's GILD Position: Q3 2016 in Review

Nebula Capital Management sold out of Gilead Sciences (GILD) in Q3 2016, closing a stake of 9,650 shares — an estimated $805K sold.

Nebula Capital Management first reported a position in GILD in Q1 2015 and held it in 6 quarters. The position peaked at $6.91M in Q2 2015. 1,557 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

Nebula Capital Management reported no remaining Gilead Sciences position as of Q3 2016 after selling out during the quarter.
Nebula Capital Management sold 9,650 Gilead Sciences shares in Q3 2016, an estimated $805K.
Nebula Capital Management first reported a position in Gilead Sciences in Q1 2015 and held it in 6 quarters.
Nebula Capital Management's Gilead Sciences position peaked at $6.91M in Q2 2015.
1,557 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on Nebula Capital Management's 13F filing for Q3 2016, filed 16 Nov 2016.